Breaking News

  • 44 minutes ago

  • Simantini Singh Deo

Actuate Therapeutics, Inc. Launches Expanded Research Program To Test Elraglusib In Combination With Emerging RAS-Targeted Therapies
Breaking News

More News

AEON Biopharma, Inc. Appoints John Bencich As Chief Financial Officer Ahead Of Key Regulatory Milestones

AEON Biopharma, Inc. Appoints John Bencich As Chief Financial Officer ...

Simantini Singh Deo

Biofrontera Inc. Reports Positive Phase 2b Results Supporting Continued Development Of Ameluz Photodynamic Therapy For Moderate To Severe Acne Vulgaris

Biofrontera Inc. Reports Positive Phase 2b Results Supporting Continue...

Simantini Singh Deo

Cytek Biosciences Marks One Year Of Its 8,500-Sq-Ft Singapore Facility As APAC Expansion Reaches Major Milestone

Cytek Biosciences Marks One Year Of Its 8,500-Sq-Ft Singapore Facility...

Simantini Singh Deo

LB Pharmaceuticals Inc Adds Veteran Neuroscience Executive Robert Lenz, M.D., Ph.D. To Board Of Directors

LB Pharmaceuticals Inc Adds Veteran Neuroscience Executive Robert Lenz...

Simantini Singh Deo

Ad
Advertisement
Ad
Advertisement
Ad
Advertisement